Watson Pharma (WPI) Posts Q3 adj.-EPS of $0.66, Beats by 1c;
WPI Hot Sheet
Revenue Growth %: -99.8%Financial Fact:
Other income (expense): 1.5M
Today's EPS Names:
BRLI, TLB, TNP, More
Watson Pharmaceuticals, Inc. (NYSE: WPI) reports Q3 adjusted EPS of $0.66, 1 cent better than the analyst estimate of $0.65. Revenue for the quarter was $662.10 million, which compares to the estimate of $688.53 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- VeriFone Systems (PAY) Tops Q2 EPS by 3c; Guides Q3, FY12
- Monro Muffler (MNRO) Tops Q4 EPS by 1c; Comps About Flat; Guides FY13 EPS Below Views
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
